Potřebujeme váš souhlas k využití jednotlivých dat, aby se vám mimo jiné mohly ukazovat informace týkající se vašich zájmů. Souhlas udělíte kliknutím na tlačítko „OK“.
Standard Classification for Tissue Engineered Medical Products (TEMPs)
Automaticky přeložený název:
Standardní klasifikace pro přípravky tkáňového inženýrství léčiv (brigádníků)
NORMA vydána dne 1.10.2013
Označení normy: ASTM F2211-13
Poznámka: NEPLATNÁ
Datum vydání normy: 1.10.2013
Kód zboží: NS-53206
Počet stran: 8
Přibližná hmotnost: 24 g (0.05 liber)
Země: Americká technická norma
Kategorie: Technické normy ASTM
Keywords:
biomaterials, biomolecules, cells, classification, TEMPs, tissue-engineering, ICS Number Code 11.100.99 (Other standards related to laboratory medicine)
Significance and Use | ||||||||||
4.1 This classification outlines aspects of TEMPs which includes their individual components. 4.2 The categories outlined in this classification are intended to list, identify, and group the areas pertinent to Tissue Engineered Medical Products. This classification will be used by the Tissue Engineered Medical Products subcommittees for the organization of the development of standards for the field of tissue engineering, TEMPs, and protocols for their use. The development of products from the new tissue engineering technologies necessitates creation and implementation of new standards (1).5 4.3 Since interactions may occur among the components used in TEMPs, new standard descriptions, test methods, and practices are needed to aid the evaluation of these interactions. The degree of overall risk for any given TEMP is reflected by the number and types of tests required to demonstrate product safety and efficacy. |
||||||||||
1. Scope | ||||||||||
1.1 This classification outlines the aspects of tissue engineered medical products that will be developed as standards. This classification excludes traditional transplantation of organs and tissues as well as transplantation of living cells alone as cellular therapies. 1.2 This classification does not apply to any medical products of human origin regulated by the U.S. Food and Drug Administration under 21 CFR Parts 16 and 1270 and 21 CFR Parts 207, 807, and 1271. 1.3 This standard does not purport to address specific components coverd in other standards. Any safety areas associated with the medical product's use will not be addressed in this standard. This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory requirements prior to use. |
||||||||||
2. Referenced Documents | ||||||||||
|
Historická
1.3.2012
Historická
1.2.2013
Historická
15.10.2010
Historická
1.12.2011
Historická
1.4.2012
Historická
1.3.2011
Poslední aktualizace: 04.11.2024 (Počet položek: 2 209 323)
© Copyright 2024 NORMSERVIS s.r.o.